Functional loss in daily activity in ovarian cancer patients undergoing chemotherapy.

PURPOSE: Cancer survivors frequently experience cancer or treatment-related symptoms and functional morbidities that can be addressed through rehabilitation services, but these symptoms often go unnoticed and seldom managed. This study seeks to investigate the undetected patient symptoms and functional loss related to the activities of daily living (ADLs) in ovarian cancer patients during chemotherapy and to identify the influence of chemotherapy on such loss. METHODS: Ovarian cancer patients undergoing chemotherapy were identified from June to August 2016, who were treated at the department of Gynecology and Obstetrics of two tertiary hospitals. The questionnaires on the present cancer and treatment-related symptoms, patient recognition of rehabilitation needs, and the Katz index score were collected. RESULTS: Records of total 168 ovarian cancer patients were selected and reviewed. The majority of patients (93.5%) experienced at least one symptom, with paresthesia (76.2%), fatigue (63.1%), pain, muscle weakness, memory and concentration dysfunction, lymphedema, breathing discomfort, dysphagia, and speech difficulty being the primary complaints in descending order. About 20% of ovarian cancer patients under chemotherapy had functional dependence in ADLs. The most affected ADL functions were continence, bathing, transfer, and dressing in descending order. Fatigue symptom and the functional dependence showed a significant correlation in proportion to the total number of chemotherapy cycles. CONCLUSIONS: There are undetected symptoms and functional loss in ovarian cancer patients during chemotherapy, which aggravated in relation to the increase in accumulated chemotherapy. Timely and appropriate rehabilitative intervention may help minimize these symptoms and functional loss, and further contribute to the improved quality of life.